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Abstract 
 
 The United States has experienced a serious and growing opiate epidemic over the past 
20 years. North Carolina has been identified as a state of particular concern along with other 
Southern and Appalachian states. This study characterizes the opiate epidemic in North Carolina 
along three axes: space, time, and drug type. Using data from the North Carolina State Center for 
Health Statistics, I calculated county-level mortality rates for prescription opioids, methadone, 
synthetic opioids, and heroin for each year from 1999 to 2015. Then I performed mean center, 
cluster, and spatial regression analyses to identify areas of high and low mortality rates and 
associated socioeconomic correlates. My results show that mortality due to prescription opioids 
in North Carolina increased by 612 percent and heroin increased by 800 percent over the study 
period. Average mortality rates from prescription opioids were highest in the western, 
Appalachian counties, while the highest rates for heroin mortality occurred in urban counties 
along the Piedmont Crescent and in Wilmington. Mean center analysis by year showed 
prescription mortality rates were pulled to the west during the entire study period with a notable 
trend east in 2014 and 2015. Heroin mortality rate mean centers were consistently east of the 
unweighted mean center, although they also showed a higher variance. Discrete Poisson-based 
cluster models in SaTScan identified high clusters of mortality rates for both drug types in 
similar areas as the descriptive analysis, however it also determined intraregional hotspots 
including Richmond and Carteret counties for prescription opioid mortality. Regression models 
for average mortality rate by county for the entire study period for prescription opioids and 
heroin produced R squared values of 0.62 and 0.36 respectively. Prescription opioid mortality 
increased with percent with disability and decreased with percent Black and percent Hispanic. 
Heroin mortality increased with urbanity and decreased with percent holding a college degree. 
This study confirms trends in the opiate epidemic with high rates of prescription opioid mortality 
among White, rural, Appalachian counties and heroin mortality in urban areas. Policymakers and 
intervention workers can use these findings to develop appropriate measures to combat this 
epidemic and target their work based on place and drug type. 
 
Introduction 
 
Over the past 20 years the United States has experienced a well-documented epidemic of 
unintentional drug poisonings. According to the Centers for Disease Control and Prevention 
(CDC) unintentional drug poisonings are the second leading cause of injury death in the United 
States behind motor-vehicle crashes and the top cause of death for 35 to 54 year olds (Warner et 
al., 2009). The major driver of this trend is the rise in use and abuse of prescription opioids. In 
2002, implication of opioid analgesics in poisoning deaths was 36.5 percent and 29.4 percent of 
deaths were from opioids alone (Paulozzi, 2006). From 1999 to 2002, deaths involving opioid 
analgesics increased by 91.2 percent and deaths from heroin use increased 12.4 percent 
(Paulozzi, 2006). Deaths rates from drug overdose have increased exponentially over the past 20 
years from 6.2 per 100,000 in 2000 to 14.6 per 100,000 in 2014, largely due to increases in 
prescription opioid deaths (Rudd, 2016). 
Regular opioid use has been shown to increase with age, female gender, and non-
Hispanic White race/ethnicity, whereas it decreases with respect to increasing years of education 
(Kelly, 2008). However, poisoning deaths from opioid analgesics are highest among middle-aged 
men (Paulozzi, 2006; CDC, 2007; Green et al., 2010). Opiate poisoning deaths also vary by 
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urban-rural status. While traditionally thought of as an urban phenomenon, rural counties have 
come to replace urban counties as the hotbed of opiate poisoning mortality. Large metro counties 
had the highest rate of opioid analgesic mortality in 1999, but by 2004 they were replaced by 
rural counties whose mortality rate increased by 371 percent since 1999 to 3.85 deaths per 
100,000 (Paulozzi and Xi, 2008). Other studies have shown that this increase is due to 
prescription opioids such as oxycodone and methadone versus traditionally injected substances 
such as heroin and cocaine (Havens, 2007; Paulozzi and Xi, 2008; Paulozzi et al, 2009; 
Ballesteros, 2003; Dasgupta et al, 2008). This trend shows that increases in overdose and 
mortality are due to licit prescription drugs instead of illicit drug use as deaths due to heroin and 
cocaine have remained steady (Paulozzi and Xi, 2008; Dasgupta et al., 2008; Unick et al., 2013). 
Opiate overdose and death in North Carolina have largely followed national trends. Sales 
of prescription opioids in North Carolina have had staggering increases over the past 20 years. 
Sales in the state from 1997 to 2010 jumped 183 percent for morphine, 224 percent for 
hydrocodone, 291 percent for hydromorphone, 530 percent for Fentanyl, 607 percent for 
methadone, and 839 percent for oxycodone (Modarai et al., 2013). These increases were also 
found to be clustered in space with the highest prescribing 3-digit zip codes in the western part of 
the state. Only two prescription opioids, meperidine and codeine, had decreasing sales (Modarai 
et al., 2013); these two formulations are also weaker than the others listed above (Curtis et al., 
2006; Steinman et al., 2015). In 2007 in a study on Medicaid beneficiaries in North Carolina, 
unintentional overdose deaths were disproportionately represented in rural areas, in people 25 to 
44 years of age, and White race compared to a control sample (Whitmire and Adams, 2010). 
Among the same population, hydrocodone was the most common prescription drug among the 
decedents (Whitmire and Adams, 2010). Of particular concern in North Carolina are deaths due 
to methadone overdose. Methadone is often prescribed as a treatment for heroin addiction, but 
has been increasingly used in chronic pain management (Ballesteros et al., 2003). Methadone, 
while also addictive, is subject to very specific dosage amounts that separate therapeutic from 
harmful effects (Sanford, 2008). North Carolina experienced 5 times the amount of methadone 
overdose deaths in 2001 versus 1997 and 75 percent of these deaths were from methadone alone 
(Ballesteros et al., 2003). In 2006, methadone was implicated in 32 percent of unintentional 
overdose deaths in North Carolina despite being the 18th most prescribed controlled substance 
(Sanford, 2008). Therefore, while hydrocodones and oxycodones were the 1st and 2nd most 
prescribed controlled substances respectively in 2007, methadone was much more lethal 
(Sanford, 2008). Unintentional methadone overdose deaths were also found to be concentrated in 
the western part of North Carolina (Sanford, 2008). 
This rise in opiate overdose and death in the past 20 years is of serious public health 
concern. Opioid analgesics are highly addictive and patients must be aware of the consequences 
of regular use and abuse (Wright et al., 2014). Several studies have documented abuse of 
prescription opioids (e.g. injection, tearing patches, etc.) for nonmedical use with a greater risk 
for overdose and death (Paulozzi et al., 2006; Kelly et al., 2008; Havens et al., 2007). While 
opioid analgesics are important for proper medical treatment of acute and chronic pain (Steinman 
et al., 2015), overprescribing is dangerous to public health. On the other hand, it is in the interest 
of public health to avoid underprescribing opioids in pain management, especially among older 
adults (Steinman et al., 2015). Beyond the individual health effects, increasing sales of 
prescription opioids have fueled increases in diversion to vulnerable populations as well as 
“doctor shopping” to obtain more prescriptions (Rossen et al., 2013; Modarai et al., 2013; Unick 
et al., 2013; Mazumdar et al., 2015). 
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Both licit and illicit use and sales of opioids show heterogeneous patterns in space. 
Overdose deaths are concentrated in space at different scales. Studies in urban areas have found 
clusters of overdose deaths in specific neighborhoods known to be active areas of drug marketing 
(Scott et al., 2007; Taylor and Clermont, 2000). Most overdose deaths occur at the site of 
overdose (Dasgupta et al., 2008; Scott et al., 2007). Opiate overdose clusters were also found to 
correlate in space in areas with high rates of poverty, non-White populations, and a history of 
public housing (Scott et al., 2007). These urban patterns stand in stark contrast to other studies 
that have found a disproportionate and increasing burden on rural areas of the country at a wider 
spatial scale. Studies in Connecticut, New Mexico, and New Hampshire found spatial clustering 
of high overdose death rates in rural areas (Green et al., 2011; Brownstein et al., 2010; Hester et 
al., 2012). Green et al. (2011) found that geography was also influenced by drug type with heroin 
and methadone represented in urban areas versus a higher concentration of prescription opioid 
overdose in rural areas. Furthermore, the importance of estimating underlying product 
availability is paramount. Brownstein et al. (2010) initially found clusters of prescription opioid 
abuse in urban centers, but after accounting for drug prescribing rates, the clusters moved to rural 
areas. Prescription opioid sales are also unevenly distributed in space. In the United States, the 
highest rates of prescription opioid sales were found in Appalachian, southern, and western 
counties, while the lowest rates were in the Midwest, New England, and Alaska (McDonald et 
al., 2012). This distribution was positively correlated with county population proportion White 
non-Hispanic, active physicians, and urban, poor, uninsured, African-Americans (McDonald et 
al., 2012). Prescription opioid sales in North Carolina were found at higher rates in rural 3-digit 
zip codes in the southern and western portions of the state (Modarai et al., 2013). 
The objective of this study is to describe trends in opiate overdose death in North 
Carolina over space and time at the county level from 1999 to 2015. Using advanced clustering 
and statistical analysis, I hope to identify areas of high (and low) concentration of opiate 
overdose deaths. Finally, I seek to identify correlates in space and time to characterize the 
geographic patterns and give context to the rise in overdose deaths. 
 
Research Questions 
 
 How have opiate overdose deaths changed in North Carolina from 1999 to 2015 across 
counties in the state? Where are opiate overdose death hotspots and what factors are associated 
with these increased rates? 
 
Literature Review 
 
 Most of the work done on the epidemic of opiate overdose and death has been strictly 
epidemiological. These studies pioneered exposing this epidemic, which often occurs in “hidden 
populations” (Havens et al., 2007; Mazumdar et al., 2015; Scott et al., 2007). As a result, many 
studies are descriptive in nature focusing on person and time with few looking in depth at 
potential causes and geography. 
 One of the first studies to consider the role of prescription opioid analgesics in the rise of 
opiate deaths since the late 1990s was investigated by Paulozzi et al. (2006). This was the first 
study to not only show the dramatic increases in opiate deaths, but also the first to compare 
opioid analgesic abuse versus “street drugs” such as heroin and cocaine (Paulozzi et al., 2006). 
This distinction is crucial in understanding how the dynamic of the current epidemic is different 
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from drug epidemics in the past. The abuse of prescription opioid analgesics manifests itself in 
different ways demographically and geographically from other forms of drug abuse, particularly 
the contrast in legality between the two forms. The Paulozzi et al. (2006) study used medical 
coroner mortality data from the National Center for Health Statistics (NCHS), selecting 
poisoning deaths using the Ninth Revision of the International Classification of Diseases (ICD-9) 
for 1979 to 1998 and the Tenth Revision (ICD-10) for 1999 to 2002. The authors calculated 
simple mortality rates for the different drug types, comparing opiates to psychotropics, cocaine, 
and other drugs, showing the vast increases in the mortality rate for all drugs except 
psychotropics in the early 1990s (Paulozzi et al., 2006). It is important to note that ICD-9 does 
not differentiate between types of opioid deaths; under the system, a heroin poisoning death 
would be coded the same as an oxycodone poisoning death. Since 1999 with the adoption of 
ICD-10, medical coroners now define poisoning deaths according to different opioid analgesics 
(methadone, other opioids, other synthetic narcotics) as well as heroin (WHO, 1992). The study 
also compared the change in sales of prescription opioid analgesics in the last part of the time 
period from 1999 to 2002. Using morphine equivalents, the authors compared the relative risk of 
mortality compared to sales across different prescription types (Paulozzi et al., 2006). The 
highest risk of mortality per sales occurred in the “other opioids” category including oxycodone 
and codeine; however, the authors note that the ratio only increased from 1999 to 2002 for 
methadone, indicating it was becoming more deadly, a finding that was corroborated by future 
studies (Paulozzi et al., 2006; Sanders, 2008). 
 After this first effort to document the rise on opioid deaths and the new role of 
prescription opioid analgesics, subsequent studies sought to discover nuances in the trend. Two 
studies, Kelly et al. (2008) and Unick et al. (2013), identified trends in opioid use short of 
mortality by examining trends in regular use and overdose. Using a random digit dialing 
telephone survey, Kelly et al. (2008) found that regular opioid use was higher among older adults 
and females, but lower among highly educated and African-American participants. There were 
regional geography considerations with higher regular opioid use in South Central states (AL, 
AR, KY, LA, MS, OK, TN, TX) versus the rest of the United States (Kelly et al., 2008). 
Hydrocodone was used the most among regular users (21%) and the vast majority only used oral 
administration (95%) (Kelly et al., 2008). While showing that the demographics of regular 
prescription opioid use generally follow those for mortality, that there is a trend towards stronger 
opioid use, and that regular opioid use is different for different regions of the county, land-line 
random digit dialing sampling is subject to potential bias because it misses young, urban cell 
phone users, a significant portion of the vulnerable population. Looking at the middle ground 
between regular use and mortality, Unick et al. (2013) studied the differences between heroin 
and prescription opioid overdoses. Using data from the National Inpatient Sample (NIS), the 
authors had the advantage of a long time series, 1993 to 2009, which showed the start of the 
dramatic increases in overdose and death due to prescription opioids in the mid-1990s and their 
exponential increase up to 2009. The difference between overdose and mortality trends is 
especially important for heroin use. Heroin overdose increased exponentially from 2005 to 2009 
but heroin mortality stayed relatively constant over the study period (Unick et al., 2013). Using a 
negative binomial lag model, the authors showed that an increase in heroin overdose could 
predict the subsequent year’s increase in prescription opioid overdose while holding other 
variables constant (Unick et al., 2013). The study also added support for the greatest increases in 
prescription opioid overdoses occurring in White, female, and middle-aged populations, with 
decreasing rates among African-Americans (Unick et al., 2013). 
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Several studies have highlighted the need for more geography-minded, area-level studies 
on opiate abuse (Thomas et al., 2008; Hester et al., 2012; Taylor and Clermont, 2000; Scott et al., 
2007; Brownstein et al., 2010; Mazumdar et al., 2015) By definition, public health occurs at the 
population level and ecological studies are necessary to understand the contextual factors driving 
this epidemic. Spatial analysis can reveal “hot spots” of opiate use, overdose, and mortality, 
which can be used by local authorities to direct targeted public health interventions. Many 
studies employ a social-ecological model to illustrate the effects of communities, local services, 
state policies, and national campaigns on individual drug use (Monnat et al., 2016; Thomas et al., 
2008). Area level studies can serve to identify how these different layers interact to promote or 
prevent opiate abuse. Using the county as the unit of analysis in this study is particularly helpful 
because county health departments are often the key actors in addressing local drug abuse issues, 
setting policies, and running health clinics (Albert et al., 2011). Other spatial scales such as the 
state level may mask important intrastate patterns (Curtis et al., 2006) or census tracts, which are 
arbitrary and may not be particularly useful for enacting policy changes (Hester et al., 2012). 
Furthermore, spatial scales finer than the census tract are often impossible to conduct due to 
privacy concerns (Green et al., 2011; Curtis et al., 2006) and the small numbers problem (Hester 
et al., 2012; Mazumdar et al., 2015). 
A few studies used geographic methods beyond basic mapping of rates across space. Two 
studies used a spatial scan statistic model to identify clusters of high rates of mortality 
(Brownstein et al., 2010; Modarai et al., 2013). Using Poisson-based retrospective models, the 
two studies were able to characterize specific areas with mortality rates both higher and lower 
than was expected. Furthermore, the scan statistic allows for a measurement of relative risk 
within the cluster versus outside the cluster. However, both studies were conducted at the three-
digit zip code level, a scale that is relatively course for cluster analysis within states and only one 
study accounted for time in its scan statistic (Modarai et al., 2013), making space-time clustering 
analysis for opiate mortality at a fine spatial scale a novel application. One study in New 
Hampshire used mean center and standard distance analysis to identify trends in mortality over 
time (Hester et al., 2012). The study found that the mean center hovered around the same 
position and the standard radius did not change over their four-year study period. This method 
may be more informative over a longer study period with more mean centers or with a larger, 
more heterogeneous state such as North Carolina. 
With a sizeable portion of the state falling in the Appalachian region as well as large 
urban populations, opiate abuse is of particular concern in North Carolina. Several studies have 
identified lower Appalachia within the South more generally as a hot spot for opiate overdose 
and death (Rossen et al., 2013; Albert et al., 2011; Paulozzi and Xi, 2008) and prescription 
opioid sales (McDonald et al., 2012; Curtis et al., 2006). Studies in North Carolina have 
confirmed these trends at relatively course spatial scales such as 3-digit zip codes (Modarai et al., 
2013) or for all prescriptions without stratification (Sanford, 2008). Furthermore, no study to my 
knowledge has used the most recently available data from the 2010s, a period in which opioid 
abuse trends were continuing to evolve. 
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Methods 
 
Data Collection 
 
 Data on opiate poisoning deaths was obtained from the North Carolina State Center for 
Health Statistics’ Injury Free NC database (SCHS) (SCHS, 2016). This database contains records 
detailing all poisoning deaths dating back to 1999. Datasets are stratified by drug type, county of 
residence, and intent. Deaths were codified by the state medical examiner using ICD-10. Deaths 
were recorded in 5 different categories: heroin (T40.1), methadone (T40.3), other synthetic 
opioids (T40.4), prescription opioids (T40.2, T40.3, T40.4), and all opiates (T40.0, T40.1, T40.2, 
T40.3, T40.4). Deaths were counted in county yearly totals with any mention of the above codes, 
thus it is possible that a single death could be counted multiple times if the medical examiner 
recorded the presence of multiple opioids (e.g. a death including T40.1 and T40.3 would be 
counted in both the heroin dataset and the methadone dataset). In my study I add an additional 
category that separates out “other opioids” (T40.2) by subtracting methadone and other 
synthetics deaths from prescription opioids deaths. Other opioids include semi-synthetic 
prescription analgesics including oxycodone and hydrocodone in contrast to fully synthetic 
opioids such as meperidine and Fentanyl. In addition, deaths were stratified by unintentional 
(X40-44) and self-inflicted (X60-X64) intents. A summary of the categories is provided in Table 
1. 
 
Table 1. Mortality ICD-10 definitions 
ICD-10 Code Drug Type or Intent 
T40.1 Heroin 
T40.2* Other Opioids 
T40.3 Methadone 
T40.4 Other Synthetic Opioids 
T40.2, T40.3, T40.4 Prescription Opioids 
T40.0, T40.1, T40.2, T40.3, T40.4 All Opiates 
X40-X44 Unintentional 
X60-X64 Self-Inflicted 
*Calculated by subtracting methadone and other synthetics from prescription opioids. 
 
The NC Center for Health Statistics also publishes hospitalization data since 2004 and 
emergency department visits since 2008; however, due to privacy concerns, any values less than 
13 are suppressed, resulting in inconsistent data across counties. This study elected to use only 
the fully reported mortality data to ensure that all counties were considered in the analysis and to 
take advantage of the longer time series. Yearly county population estimates, median age, and 
race characteristics were obtained from the North Carolina Office of the State Budget and 
Management (OSBM) (OSBM, 2016). The other variables in the regression, including per capita 
income, poverty, educational attainment, unemployment, disability, and health insurance status 
were from the US Census Bureau’s American Community Survey 5-year estimates for 2009 to 
2013 (my reference year), retrieved via the National Historical Geographic Information System 
(NHGIS) (Minnesota Population Center, 2016). I used the USDA’s county urban-rural 
designation codes from 2013 (USDA ERS, 2013). The codes range from 1 (metro counties in 
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areas of over 1 million people) to 9 (nonmetro, completely rural counties not adjacent to a metro 
area). 
 
Data Analysis 
 
 Using the population estimates and number of deaths, I calculated and mapped yearly 
mortality rates for each drug and intent category for every county as well as average rates over 
the study period 1999 to 2015. I also determined yearly differences in mortality rate and an 
average measure of year-on-year increases for each county. In order to determine how mortality 
rates were distributed spatially within the state, I performed a mean center analysis of the 
counties weighted by their respective mortality rates for each year for both prescription opioids 
and heroin. To understand the relative variability in the mean centers, I calculated a one standard 
deviation distance measure around the average location of all the mean centers for each drug 
type. This method allows me to examine how the mortality patterns function in three dimensions: 
space, time, and drug type. I conducted space-only and space-time cluster analysis using 
SaTScan 9.0 (Kulldorff, 2010). SaTScan uses case, population, and coordinate files to create a 
space-time representation of mortality occurrence. Cases were identified as the raw numbers by 
county by drug type. The population file consisted of the OSMB county population estimates. 
The SaTScan coordinate file requires point locations for analysis; therefore, I calculated county 
centroids to represent each county area. After creating this space-time distribution, the software 
develops variable sized cylinders based on a specified model to identify county clusters of high 
and low occurrence by comparing rates inside the cylinder to those outside while providing 
associated statistical significance measures. The software also reports relative risk measures for 
significant clusters, comparing counties inside versus outside. I selected a discrete Poisson-based 
model to evaluate clusters because of the positively skewed nature of opiate poisoning deaths 
(Scott et al., 2007; Brownstein et al., 2010; Hester et al., 2012). My first analysis considered only 
the spatial dimension by drug type using data across all years. In this model, the cylinders are 
compressed in time and become circles of varying radii. My second analysis involved true 
cylinders to identify space-time clusters of high and low rates using a retrospective Poisson 
model. SaTScan has been used successfully to study prescription opioid abuse clusters 
(Brownstein et al., 2010) and prescription opioid sales and overdoses (Modarai et al., 2013). 
 In order to identify potential variables associated with the mortality trends, I pursued a 
regression analysis. Since I did not have data for every county for every year, I created a cross-
sectional analysis using 2013 as the reference year for demographic, socioeconomic, and urban-
rural status variables. Potential correlates included race, age, educational attainment, poverty, 
unemployment, disability, per capita income, and health insurance. The dependent variables 
were average mortality rates over the study period per 100,000 people per county for both heroin 
and prescription opioids. To start, I performed a simple ordinary least squares (OLS) regression 
between all socioeconomic variables and each mortality rate average. I refined my model by 
checking the multicollinearity condition number and removing any variables with significance 
below 0.05. As I removed variables, I compared successive models for improvement by using 
the Akaike information criterion (AIC). The AIC is a relative measure of model fit; lower AIC 
values indicate better fit. After obtaining the best model using OLS for heroin and prescription 
opioid mortality, I checked the mortality rates for spatial autocorrelation using Moran’s I and 
conducted a spatial lag regression model, which takes into account observation distance in space 
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as an additional term. All regression analysis was conducted in GeoDa 1.8 (Anselin et al., 2006). 
All maps were produced using ArcMap 10.4 (ESRI, Redlands, CA). 
 
Results 
 
 Over the study period there were 11,072 deaths due to opiate poisoning. Of these, 1,656 
involved heroin, 4,223 involved semi-synthetic prescription opioids, 3,446 involved methadone, 
and 2,048 involved a fully synthetic prescription opioid. Together, prescription opioid poisoning 
contributed to 9,717 deaths in North Carolina over 16 years. Every drug category showed an 
increase from 1999 to 2015. Heroin raw mortality figures had an 800 percent increase. 
Prescription opioid mortality increased by 612 percent, with synthetics seeing the highest percent 
increases (1,008 percent) in this category followed by semi-synthetics (870 percent) and 
methadone (134 percent). The yearly mortality data for the entire state shows generally 
increasing trends in mortality rates throughout the study period (Figure 1). Prescription opioid 
poisoning mortality rates climbed in a linear fashion from 1999 to 2008, but saw a decline from 
2009 to 2013 before another uptick in 2014 and 2015. Heroin poisoning mortality rates stayed 
relatively constant from 1999 to 2011, but saw a linear rise from 2012 onwards. Specific 
prescription opioid types also varied during the period (Figure 2). Methadone was the most 
common reason for mortality in the first part of the study period up to 2007 when it was 
surpassed by semi-synthetic opioids. While deaths due to methadone declined after 2007, semi-
synthetic and fully synthetic opioid mortality rate figures remained constant from 2008 to 2013. 
Both also showed an increase in 2014 and 2015, in which fully synthetic mortality rates moved 
above those for methadone. 
  Figure 1 
Figure 2 
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 Opiate deaths in North Carolina stratified by intent showed that the vast majority of 
poisonings were unintentional. Self-inflicted opiate poisoning deaths represented 1,021 incidents, 
of which 1,012 were due to prescriptions rather than heroin. Unintentional poisoning deaths were 
much more common, accounting for 90.4 percent of deaths during the period. Since self-inflicted 
intents do not represent a major portion of overall deaths and remained relatively constant 
through the study period, the remainder of the analysis will treat all opiate poisoning deaths 
equally with regard to intent. 
 Average mortality rates for all counties stratified by heroin versus prescription opioids 
are included in the Appendix. The mortality rate maps by county showed different spatial 
patterns for different drug types. The statewide average mortality rate from all opiate poisoning 
deaths was 7.04 deaths per 100,000 with a standard deviation of 4.24 deaths. Average mortality 
rates over the study period were higher in western counties versus eastern counties (Figure 3). 
Burke, Cherokee, Mitchell, Swain, and Wilkes counties had average mortality rates above two 
standard deviations from the statewide mean. All five counties are in the mountainous 
Appalachian region. A notable outlier is McDowell County where the mortality rate was less 
than one standard deviation below the mean. In contrast, many rural northeastern counties had 
overall opiate mortality rates much lower than the state mean. These counties included Bertie, 
Duplin, Chowan, Gates, Greene, Hertford, Hyde, Northampton, Tyrrell, Warren, Washington, 
and Wilson. Warren County had the lowest average mortality rate at 0.86 opiate poisoning deaths 
per 100,000, while Wilkes County had the highest average mortality rate at 20.72 opiate 
poisoning deaths per 100,000. 
 
 
Figure 3 
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 The pattern remains relatively the same for prescription opioid mortality overall as well 
as the different prescription categories. The average prescription opioid mortality rate for the 
state was 6.20 deaths per 100,000 with a standard deviation of 4.24 deaths. The highest mortality 
rates included the same five counties identified for all opiates with the addition of Yancey 
County, which borders Mitchell County to the south (Figure 4). Wilkes County continues to have 
the highest mortality rate with 20.48 prescription opioid poisoning deaths per 100,000, which is 
more than three standard deviations above the state mean when only considering prescription 
opioids. This shows that the major driver behind opiate mortality in Wilkes County (and 
Appalachia more generally) is due to prescription opioid abuse versus heroin. McDowell County 
remains a low outlier among the far western counties. Among counties with low prescription 
opioid mortality rates are the same counties listed above in the eastern part of the state. The 
lowest average mortality rate remains with Warren County at 0.86 prescription opioid poisoning 
deaths per 100,000. Of note is the addition of Mecklenburg County (Charlotte), which had an 
average prescription opioid mortality rate below one standard deviation of the state mean. 
 
 
Figure 4 
 
Methadone mortality rates showed similar east-west trends; however, the counties with 
the very highest rates (greater than three standard deviations) shifted to Cherokee, Mitchell, and 
Yancey counties, while Wilkes County dropped to between one and two standard deviations 
above the state mean (𝑥=2.25, 𝜎=1.91) (Figure 5). Therefore, the spatial distribution of mortality 
within prescription opioids is heterogeneous. The county with the highest mortality rate from 
methadone poisoning was Cherokee County at 9.82 deaths per 100,000. Counties with 
methadone mortality rates below one standard deviation of the state mean were again 
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concentrated in the northeast, but more restricted including only Bertie, Greene, Hertford, 
Tyrrell, Warren, and Washington counties. Two counties, Hyde and Tyrrell, had no deaths due to 
methadone over the study period. 
 
 
 
Figure 5 
 
Synthetic opioid poisoning mortality rates also had the general east-west pattern; 
however, with some significant differences (Figure 6). Additions to the highest county category 
(between two and three standard deviations above the state mean of 1.29 with standard deviation 
0.89) included Avery County to the east of Mitchell, Alleghany County to the north of Wilkes, 
and Transylvania County along the South Carolina border. Alleghany County had the highest 
rate of synthetic opioid poisoning mortality at 3.72 deaths per 100,000, a county that was not in 
the highest group for all opiates, prescription opioids, or methadone. Moreover, many of the 
northeastern counties move closer to the state mean. Only Greene, Martin, Northampton, 
Warren, and Wilson counties remain below one standard deviation and Camden County in the 
extreme northeast actually has a mortality rate more similar to western counties (3.60 per 
100,000). Instead, the lowest rates for synthetic opioid mortality occur in urban counties such as 
Durham, Wake, Orange, Mecklenburg, and Union. Northampton County was the only county 
that did not have any deaths due to synthetic opioids over the study period. 
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Figure 6 
 
 Heroin poisoning mortality rates followed a different spatial pattern in North Carolina 
versus prescription opioids. High heroin mortality appears in isolated pockets around the state, 
emblematic of a more urban phenomenon (Figure 7). Counties with mortality rates above one 
standard deviation from the statewide mean (𝑥=1.03, 𝜎=0.67) included Durham, Guilford, 
Forsyth, and Randolph, with even higher rates occurring in Gaston and Brunswick (between two 
and three standard deviations above) and New Hanover (more than three standard deviations 
above). However, isolated counties with high rates also included Camden, Dare, Halifax, and Pitt 
as well as Vance, which is just barely above three standard deviations from the mean. New 
Hanover is far and away the county with the highest heroin mortality rate at 3.56 deaths per 
100,000. Many counties with the lowest mortality rates occurred in the far west along the 
Georgia and Tennessee borders as well as select counties in the east. All seventeen of these low 
rate counties had no heroin deaths from 1999 to 2015. 
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Figure 7 
 
 Yearly weighted mean center analysis for prescription opioid mortality versus heroin 
mortality showed stark differences (Figure 8). Prescription opioid mortality tended to lean west, 
with all weighted mean centers falling west of the un-weighted state center. The 2010 
prescription opioid mean center fell the farthest west, beyond a one standard deviation distance. 
Of particular note for prescription opioids is the trend east toward the un-weighted mean center 
in 2014 and 2015, suggesting that the latest uptick in prescription opioid mortality identified in 
the descriptive statistics may be more spatially balanced in North Carolina. Due to fewer cases 
and lower rates, the yearly mean center for heroin mortality is more sporadic; however, most 
points fall east of the un-weighted state mean center. Emblematic of this sporadic nature is the 
difference between the mean center for 1999, which occurs west of the state mean center, and for 
2001, which falls far to the east of any other point. Furthermore, the distance indicating a one 
standard deviation distance is larger for heroin than for prescription opioids, suggesting that the 
spatial pattern of heroin mortality has higher variation during the study period. 
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Figure 8 
 
 The results of the SaTScan space-only cluster analysis largely mirror the patterns found 
in the descriptive statistics. The model identified 17 significant clusters for prescription opioid 
mortality rates and 16 significant clusters for heroin mortality rates. The scan statistic found high 
spatial clusters for prescription opioids in the western part of the state as well as in Carteret and 
Richmond counties (Figure 9). The highest relative risk occurred in the cluster centered on 
Wilkes County in the northwest at 2.24 times the risk of prescription opioid poisoning mortality 
within those counties versus outside those counties. Clusters of lower than expected mortality 
rates occurred in eastern North Carolina and in urban areas (Figure 9). The clusters with the 
lowest relative risk were Wake and Mecklenburg counties, both urban core, with 0.41 and 0.44 
times the risk of prescription opioid mortality respectively. Clusters of high heroin mortality 
rates appeared almost exclusively in urban counties (Figure 10). New Hanover and Brunswick 
counties had the highest relative risk at 3.47, but major parts of the Piedmont Crescent also 
showed high relative risk including Mecklenburg (1.6) and Durham (1.56) counties. Significantly 
low clusters of heroin mortality occurred in rural areas, without a clear regional pattern. Low 
relative risks were found in the northeast (e.g. Harnett, 0.3), south (e.g. Robeson, 0.22), and west 
(e.g. Mitchell, 0.39). 
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Figure 9 
 
 
Figure 10 
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 The SaTScan space-time retrospective discrete Poisson model identified fewer and larger 
high-low clusters. The scan statistic found two significant clusters each for prescription opioids 
and heroin in space and time. There was a high cluster for prescription opioid mortality in 
western North Carolina from 2005 to 2012 with a relative risk of 2.28. In addition, there was a 
low cluster in the northeastern part of the state (including the Triangle region) with a relative risk 
of 0.44 from 1999 to 2006. For heroin mortality, the model identified two clusters with high 
relative risks including the greater Charlotte-Triad area at the end of the study period from 2013 
to 2015 (3.57) and the greater Triangle area also at the end of the study period from 2012 to 2015 
(2.74). 
 The OLS regression results incorporating all variables for prescription opioids are 
presented in Table 2. The model yielded an adjusted R squared of 0.627, but its multicollinearity 
condition number was 1109.5 and nine variables were not statistically significant contributors to 
the model (p>0.05). The AIC was 489.4. 
 
Table 2. OLS Regression for Prescription Opioid Mortality 
Variable Coefficient Standard Error p-value 
Constant 181.622 61.386 0.004** 
Median Age 0.186 0.117 0.115 
Percent American Indian -2.070 0.683 0.003** 
Percent Asian -1.680 0.830 0.047* 
Percent Black -2.130 0.635 0.001** 
Percent White -1.910 0.632 0.003** 
Percent Hispanic -0.249 0.087 0.006** 
Urban-Rural Designation -0.261 0.150 0.086 
Percent below Poverty Line 0.056 0.122 0.646 
Percent Unemployed 0.006 0.135 0.966 
Percent with Disability 0.335 0.126 0.009** 
Percent Uninsured 0.176 0.131 0.185 
Percent Less than High School 0.259 0.188 0.171 
Percent High School 0.008 0.154 0.958 
Percent College 0.317 0.246 0.201 
Per Capita Income -0.000 0.000 0.243 
*p<0.05, **p<0.01 
 
After four rounds of elimination, Table 3 shows the final model for prescription opioid 
mortality with an adjusted R squared of 0.606. The model reduced the multicollinearity condition 
number to 14.1 and the number of contributing variables to three: percent Black, percent 
Hispanic, and percent with a disability. The AIC (484.4) was lower than the original model. 
The Moran’s I calculation on prescription opioid mortality rates was statistically 
significant (0.49, p<0.001), therefore I created a spatial lag model using the three variables 
identified above; the results are in Table 4. The spatial lag model improved the R squared to 
0.629 while maintaining an AIC of 484.0. The coefficients for both percent Black and percent 
Hispanic were negative, while the percent with a disability coefficient was positive. 
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Table 3. OLS Regression Final Model for Prescription Opioid Mortality 
Variable Coefficient Standard Error p-value 
Constant 7.000 1.530 0.00001** 
Percent Black -0.206 0.018 0** 
Percent Hispanic -0.143 0.070 0.044* 
Percent with Disability 0.349 0.079 0.00003** 
*p<0.05, **p<0.01 
 
 
Table 4. Spatial Lag Regression for Prescription Opioid Mortality 
Variable Coefficient Standard Error p-value 
Constant 5.450 1.720 0.002** 
Percent Black -0.182 0.022 0** 
Percent Hispanic -0.122 0.069 0.077 
Percent with Disability 0.335 0.078 0.00002** 
*p<0.05, **p<0.01 
 
 The OLS regression for heroin mortality rates for all variables achieved an adjusted R 
squared of 0.284 (Table 5). The multicollinearity condition number was 1109.5 and the AIC was 
186.9. Successive rounds of correlate elimination produced a final model including only urban-
rural code designation and percent with a college degree as significant predictors of heroin 
mortality rate variation (Table 6). The adjusted R squared fell to 0.259 and the multicollinearity 
condition number was reduced to 8.65. The AIC dropped to 178.8. 
 
Table 5. OLS Regression for Heroin Mortality 
Variable Coefficient Standard Error p-value 
Constant -5.620 13.522 0.679 
Median Age -0.044 0.150 0.770 
Percent American Indian -0.111 0.183 0.545 
Percent Asian -0.029 0.140 0.834 
Percent Black -0.030 0.139 0.830 
Percent White -0.025 0.019 0.200 
Percent Hispanic -0.064 0.033 0.055 
Urban-Rural Designation -0.039 0.026 0.135 
Percent below Poverty Line 0.028 0.027 0.296 
Percent Unemployed -0.000 0.030 0.991 
Percent with Disability 0.017 0.028 0.548 
Percent Uninsured -0.008 0.029 0.793 
Percent Less than High School 0.108 0.041 0.010* 
Percent High School 0.067 0.034 0.053 
Percent College 0.114 0.054 0.038* 
Per Capita Income 0.000 5.20E-05 0.007** 
*p<0.05, **p<0.01 
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Table 5. OLS Regression Final Model for Heroin Mortality 
Variable Coefficient Standard Error p-value 
Constant 0.650 0.244 0.009** 
Urban-Rural Designation -0.094 0.026 0.0004** 
Percent College 0.035 0.013 0.009** 
*p<0.05, **p<0.01 
 
The Moran’s I statistic showed spatial autocorrelation in heroin mortality rates (0.29, 
p<0.001) and a spatial lag model using urban-rural codes and percent with a college degree 
improved the R squared to 0.360 (Table 7). The AIC also improved to 171.6. The coefficient for 
urban-rural code was negative, while percent with a college degree was positive. 
 
Table 5. Spatial Lag Regression for Heroin Mortality 
Variable Coefficient Standard Error p-value 
Constant 0.280 0.242 0.247 
Urban-Rural Designation -0.067 0.024 0.006** 
Percent College 0.036 0.012 0.003** 
*p<0.05, **p<0.01 
 
Discussion 
 
 The results of this study were consistent with many previous studies regarding the opioid 
epidemic in the US over the past twenty years. Spatial patterns differed by drug type. 
Prescription opioid mortality rates were higher among western, Appalachian counties, while 
heroin mortality rates were higher among urban counties. The mean center analysis confirms this 
finding in space and time. The mean center for prescription opioid mortality rates was 
consistently west of the un-weighted mean center, demonstrating the pull of the disproportionate 
burden of those western, border counties. The small radius of the one standard deviation circle 
shows little variation in the pattern over time, suggesting that this is a long-term problem 
stretching through the period of study and beyond. One finding of particular note for prescription 
opioids is that the last two years’ mean center points were drifting farther east toward the un-
weighted mean center. Future monitoring of prescription opioid mortality will have to determine 
whether these points are a product of natural variation or defining a trend towards a more 
balanced burden in the state. Heroin mean center analysis showed much higher variation over the 
study period due to the lower incidence and more erratic behavior of heroin mortality. However, 
heroin mortality was concentrated towards the eastern part of North Carolina for much of the 16-
year period, although it is less consistent than prescription opioids. This east-west, prescription 
opioid-heroin distinction is important for understanding how different communities in North 
Carolina are affected by opiate misuse and how consistent the epidemic has been over time. 
 The cluster analysis highlighted counties of particular concern, locations of highest 
priority for intervention efforts. Highly significant clusters for prescription opioid mortality 
appeared around Wilkes County, but also in Carteret County and Richmond County, areas not 
identified through simple descriptive statistics. Pockets of unexpectedly high mortality in these 
counties cannot be overlooked despite the generally low mortality rates of their surrounding 
counties. The benefit of cluster analysis is locating these intra-region patterns, which may be 
missed by statewide statistical analysis. Highly significant clusters for heroin mortality rates 
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occurred in New Hanover, Mecklenburg, and Durham counties, some of the largest urban 
agglomerations in North Carolina, most likely reflecting the availability of heroin as a street 
drug. 
 While it is important to focus on hot spots for high mortality, it is also beneficial to 
analyze areas of unexpected low mortality to understand potential protective effects. The lowest 
relative risk for prescription opioid morality occurred in Mecklenburg and Wake counties. This 
urban protective effect could be due to stricter regulatory practices on prescriptions in urban 
areas, the availability of heroin offsetting prescription abuse, or younger demographics that are 
less likely to have access to prescription opioids. Low clusters for heroin mortality occurred in 
rural counties across North Carolina, which may be due to the lack of availability of heroin in 
those locations or the older demographic which is less likely to abuse heroin. Future research 
should identify not only the risk factors for opiate poisoning, but also consider how communities 
are protected from increased mortality and incorporate those elements into intervention 
programs. 
 The epidemic was not static over time and the space-time clustering model identified 
moments in space and time where mortality rates were particularly high. This temporal 
dimension is important for understanding how the epidemic is changing and where it may move 
in the future. The high cluster for prescription opioids in western counties from 2005 to 2012 
suggests that the burden was highest in those counties during the middle of the study period and 
that the relative risk from 1999-2004 and 2013-2015 may not have been as pronounced. This 
finding is consistent with the mean center analysis, which found a more balanced burden of 
prescription opioid mortality towards the end of the study period. The low relative risk cluster for 
the northeast from 1999 to 2006 indicates that prescription opioid mortality for that region was 
low during the first half of the study period, but has since fallen more in line with the rest of 
North Carolina, suggesting a shift towards increasing burden in those areas. Space-time clusters 
for heroin were also indicative of changing patterns over time. Both high clusters occurred at the 
end of the study period and both were in relatively urban regions along the Piedmont Crescent. 
These clusters are of particular concern because they show recent trends of increasing heroin 
mortality rates in urban counties relative to rural counties and to their own rates earlier in the 
study period. Not only are urban counties at a higher risk of heroin mortality, but also that risk 
appears to be increasing in the past few years. Future studies should explore whether this trend 
holds or increases. 
 The regression results suggest that different socioeconomic factors may be driving the 
varying trends between prescription opioid and heroin mortality rates. The most significant 
variables associated with prescription opioid mortality were percent of the county that was 
Black, Hispanic, or had a disability, which together could predict about 62.9 percent of the 
variation in mortality rates using the spatial lag model. Counties that had higher percentages of 
Black or Hispanic residents saw disproportionately lower burdens of prescription opioid 
mortality. This finding indicates that counties with higher White populations tend to experience 
higher rates of prescription opioid mortality and are at a higher risk, which is consistent with 
both the clusters in the west region and previous studies (Kelly et al., 2008; Dasgupta et al., 
2008). Newly identified here is the percent of the county with a disability being a risk factor for 
prescription opioid mortality. This trend may be due to higher access to prescription opioids 
among this population and increased risk of abuse and overdose in this population. The 
socioeconomic variables analyzed in this study were less successful at predicting the variation in 
heroin mortality rates, only accounting for 36 percent in the spatial lag model. Significant 
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variables for heroin included a county’s urban-rural designation and its percent population with a 
college degree. The urban-rural designation was negatively correlated, meaning heroin mortality 
rates increased with increasing urbanity. This finding is consistent with my previous findings as 
well as other studies (Paulozzi and Xi, 2008). The percent with a college degree is unexpected 
because it is positively correlated with heroin mortality rates, suggesting that counties with 
higher proportions of college graduates are at a higher risk of heroin mortality. This trend has not 
been seen in the literature, but it may be a product of more highly educated urban counties, 
higher incomes that make heroin more accessible, or the disproportionate younger age of heroin 
poisoning victims. 
 This study has some limitations, which make identifying specific relationships difficult. 
First, this study is cross-sectional and thus I can make no determination of causality. Due to the 
nature of the socioeconomic variables, I was limited to mortality rate averages over the study 
period and demographic variables for reference year 2013, which may not be representative of 
county characteristics over time. Second, this study uses mortality as its outcome measure and 
does not consider overdoses or hospitalizations. While mortality is the logical extreme of misuse 
and abuse, overdoses and hospitalizations may more accurately reflect opiate abuse across the 
state, especially since urban areas have greater access to treatment centers. Third, this study was 
conducted at the area level and is subject to the ecological fallacy. Area level risks and risk 
factors presented in this study are not applicable to all individuals who compose those 
populations. 
 Future work should continue to monitor the opiate epidemic and explore whether the 
recent upticks in prescription opioid and heroin mortality rates continue in the years to come. 
Policymakers and intervention workers can use these findings to develop appropriate measures to 
combat this epidemic and target their work based on place and drug type. Recent initiatives such 
as Project Lazarus in Wilkes County have proven successful in stemming the tide of opiate 
overdose and death and further efforts of this type are recommended in counties identified as hot 
spots for mortality (Albert et al., 2011). Furthermore, the results of this study can be used to 
inform counties considering implementing Naloxone programs, an important medication used to 
reverse opiate overdose. Counties may make Naloxone training for medical and police personnel 
a priority to reduce mortality in future years. 
 
Conclusion 
 
 This study identified trends in opiate mortality in North Carolina counties from 1999 to 
2015 on three axes: space, time, and drug type. I performed analysis at a relatively fine spatial 
resolution and used a long period of study to capture nuanced trends in opiate mortality at 
different spatiotemporal scales. Consistent with the literature on opiate mortality, I found high 
rates of prescription opioid mortality in western, Appalachian counties and high rates of heroin 
mortality in urban areas. Using mean center analyses, prescription opioid mortality rates were 
concentrated towards western North Carolina, but may be trending east in recent years. 
Clustering analysis in space and time revealed high prescription opioid clusters centered on 
Wilkes County during the middle part of the study period, but the burden in these counties may 
be leveling out or waning in recent years. Meanwhile, heroin mortality rates had high space-time 
clusters in the Piedmont Crescent regions as well as in Wilmington during the latter few years of 
the study period, suggesting that rates and relative risk in these areas is increasing. Regression 
results showed that percent Black, percent Hispanic, and percent with a disability were the most 
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important factors in predicting the variation of prescription opioid mortality rates, while urban-
rural designation and percent with a college degree were most important for heroin mortality 
rates. Significant intraregional patterns also existed with Richmond and Carteret counties 
highlighted as prescription opioid mortality hotspots. Intervention programs should consider 
predominant trends in space, time, and drug type when designing implementation and future 
work should continue to analyze the dynamics of the opiate epidemic at fine spatial and temporal 
resolutions. 
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Appendix 
 
Table 6. Mortality Counts and Average Mortality Rates by County by Drug Type 
 Prescription Opioids Heroin 
County Count Rate per 100,000 Count Rate per 100,000 
Alamance 129 5.199 19 0.742 
Alexander 66 10.564 1 0.157 
Alleghany 16 8.539 1 0.526 
Anson 19 4.253 0 0.000 
Ashe 47 10.476 1 0.216 
Avery 37 12.210 0 0.000 
Beaufort 41 5.165 8 0.999 
Bertie 8 2.282 2 0.571 
Bladen 44 7.441 1 0.177 
Brunswick 212 12.294 49 2.693 
Buncombe 270 6.923 44 1.069 
Burke 251 16.523 4 0.264 
Cabarrus 198 7.028 38 1.271 
Caldwell 148 10.695 7 0.501 
Camden 14 8.511 3 1.999 
Carteret 138 12.512 10 0.878 
Caswell 21 5.229 0 0.000 
Catawba 224 8.717 25 0.961 
Chatham 34 3.216 2 0.176 
Cherokee 89 19.686 0 0.000 
Chowan 9 3.634 1 0.405 
Clay 22 12.706 0 0.000 
Cleveland 154 9.332 5 0.301 
Columbus 97 10.063 2 0.205 
Craven 125 7.379 9 0.515 
Cumberland 255 4.697 67 1.221 
Currituck 18 4.488 3 0.694 
Dare 63 10.952 10 1.752 
Davidson 234 8.663 36 1.317 
Davie 53 7.899 10 1.456 
Duplin 28 2.893 1 0.107 
Durham 148 3.371 72 1.609 
Edgecombe 36 3.818 9 0.956 
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Forsyth 329 5.660 87 1.447 
Franklin 46 4.680 9 0.842 
Gaston 405 11.892 85 2.464 
Gates 4 1.952 1 0.501 
Graham 15 10.166 0 0.000 
Granville 44 4.574 10 1.012 
Greene 5 1.470 2 0.556 
Guilford 338 4.241 126 1.549 
Halifax 34 3.655 13 1.418 
Harnett 105 5.532 6 0.346 
Haywood 114 11.622 1 0.099 
Henderson 175 10.093 5 0.274 
Hertford 8 1.964 0 0.000 
Hoke 34 4.446 1 0.120 
Hyde 3 3.049 0 0.000 
Iredell 196 7.572 31 1.128 
Jackson 64 9.800 0 0.000 
Johnston 131 4.783 15 0.535 
Jones 10 5.769 0 0.000 
Lee 64 6.704 7 0.703 
Lenoir 36 3.577 7 0.697 
Lincoln 108 8.500 15 1.133 
Macon 75 13.347 1 0.169 
Madison 54 15.522 0 0.000 
Martin 28 6.781 3 0.744 
McDowell 19 2.513 1 0.131 
Mecklenburg 430 2.853 206 1.353 
Mitchell 46 17.349 2 0.761 
Montgomery 23 4.931 2 0.423 
Moore 87 6.006 5 0.339 
Nash 60 3.807 10 0.623 
New Hanover 272 8.139 120 3.556 
Northampton 11 2.978 1 0.279 
Onslow 159 5.290 10 0.325 
Orange 92 4.226 18 0.839 
Pamlico 16 7.189 1 0.447 
Pasquotank 28 4.195 6 0.892 
Pender 63 7.226 10 1.049 
Perquimans 11 5.089 2 0.936 
Person 38 5.802 2 0.312 
Pitt 122 4.537 38 1.430 
Polk 32 9.440 0 0.000 
Randolph 171 7.210 38 1.595 
Richmond 98 12.495 4 0.514 
Robeson 102 4.543 5 0.224 
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Rockingham 141 8.960 5 0.318 
Rowan 282 12.229 34 1.450 
Rutherford 148 13.209 4 0.352 
Sampson 84 7.839 3 0.274 
Scotland 49 7.988 0 0.000 
Stanly 85 8.333 6 0.582 
Stokes 76 9.577 8 1.009 
Surry 132 10.640 6 0.484 
Swain 40 16.952 1 0.460 
Transylvania 61 11.179 0 0.000 
Tyrrell 2 2.841 0 0.000 
Union 111 3.583 31 0.924 
Vance 40 5.259 22 2.872 
Wake 378 2.625 139 0.928 
Warren 3 0.861 0 0.000 
Washington 3 1.345 0 0.000 
Watauga 50 6.044 8 0.914 
Wayne 82 4.000 21 1.019 
Wilkes 239 20.470 3 0.254 
Wilson 33 2.455 9 0.657 
Yadkin 75 11.655 9 1.399 
Yancey 50 16.471 1 0.328 
STATE 9,717 6.197 1,656 1.032 
 
